SHINEWAY PHARM (02877.HK) will release its Earnings Reports on April 23.

$SHINEWAY PHARM (02877.HK) will release its Earnings Reports on April 23, and investors are urged to pay attention. Futubull reminds: 1. There are no strict regulations on the accounting year division for companies listed on the Hong Kong and US stock markets; it is entirely determined by the companies themselves, so each earnings report period can serve as the cutoff date for the company's annual report, rather than adhering to the natural calendar year as the fiscal year. 2. Generally, the company will hold an earnings report meeting on the date of the aforementioned earnings report release or around that date, during which the company management will discuss and explain the latest quarterly earnings data and operational conditions, as well as communicate with investors, Analysts, media, and others.

Futu NewsApr 25 04:45

SHINEWAY PHARM: Annual report 2024

HKEXApr 24 16:56 · Announcements

The trial for importing beef gallbladder has been opened, causing a significant drop in the prices of the most expensive Traditional Chinese Medicine materials.

① The National Medical Products Administration and the General Administration of Customs recently jointly announced a trial for beef bile from specific countries that meet standards for production in Chinese Patent Medicine. ② The price of natural beef bile (gall bile) has dropped from a peak of 1.8 million yuan per kilogram to 1.4 million to -1.45 million yuan per kilogram.

cls.cnApr 23 22:19

Express News | The Central Committee of the Communist Party of China and the State Council: Explore the establishment of a "white list" system for imported research and development materials for Biomedical enterprises.

BreakingsApr 21 17:17

Trump Signs Executive Order on Drug Pricing -- WSJ

WSJApr 16 07:25

Caitong: Innovative Drugs and Medical Devices remain an important main line in this round of the bull market in the Medical industry.

The country is likely to accelerate the introduction of policies to encourage expanded domestic demand, which is Bullish for the sectors focused on domestic consumption, including Traditional Chinese Medicine, Medical Services, Internet medicine and pharmacies, medical aesthetics, etc., as an extension of the Health China logic.

Zhitong FinanceApr 15 11:50